Semnur Pharmaceuticals (SMNR) Cash & Equivalents (2022 - 2026)
Semnur Pharmaceuticals (SMNR) reported Cash & Equivalents of $39,000 for Q2 2026, compared with $126.00 a year earlier and down 62.1% from the prior quarter.
Powered by 
Analysis
Semnur Pharmaceuticals (SMNR) Cash & Equivalents (2022 - 2026) Analysis & Trends
At the end of FY2025, Semnur Pharmaceuticals posted Cash & Equivalents of $20,000, up 66.7% from FY2024.
- Cash & Equivalents has a three-year compound annual growth rate of -71.0% (FY2022 to FY2025).
- By year, Cash & Equivalents came in at $12,000 in FY2024 (-94.1%), $204,464 in FY2023 (-75.1%) and $819,747 in FY2022.
- Five-year quarterly Cash & Equivalents spans a low of $126.00 in Q2 2025 and a high of $1.11 million in Q2 2022.
- Year over year, Cash & Equivalents gained in four of the last six quarters, with growth averaging 109.5%.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2025 (growth of 599.9%); the low point was Q2 2023 (a decline of 99.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $103,000 (Q1 2026), $20,000 (Q4 2025) and $100,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Semnur Pharmaceuticals | 85.18 Mn | 84.92 Mn | - | 39,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39,000.00 |
| Mar 31, 2026 | 103,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 126.00 |
| Mar 31, 2025 | 2,736.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | 14,287.00 |
| Jun 30, 2024 | 1,500.00 |
| Mar 31, 2024 | 1,013.00 |
| Dec 31, 2023 | 204,464.00 |
| Sep 30, 2023 | 13,460.00 |
| Jun 30, 2023 | 9,125.00 |
| Dec 31, 2022 | 819,747.00 |
| Sep 30, 2022 | 985,578.00 |
| Jun 30, 2022 | 1.11 Mn |
| Mar 31, 2022 | 16,567.00 |
API Access
Semnur Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SMNR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SMNR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SMNR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();